ERBB2 and obesity due to melanocortin 4 receptor deficiency: Moreover, results from the randomized SUCCESS A trial demonstrated that the adverse effect of severe obesity was only found in triple negative breast cancer subgroup rather than luminal or HER2-positive subtypes31.